These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11222409)

  • 1. Drug companies sue South African government over generics.
    Sidley P
    BMJ; 2001 Feb; 322(7284):447. PubMed ID: 11222409
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug companies withdraw law suit against South Africa.
    Sidley P
    BMJ; 2001 Apr; 322(7293):1011. PubMed ID: 11325753
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug firms lose patent rights lawsuit against South Africa's government.
    Baleta A
    Lancet; 2001 Apr; 357(9265):1347. PubMed ID: 11343755
    [No Abstract]   [Full Text] [Related]  

  • 4. Generic drugs battle moves from South Africa to Kenya.
    Siringi S
    Lancet; 2001 May; 357(9268):1600. PubMed ID: 11377665
    [No Abstract]   [Full Text] [Related]  

  • 5. South Africa may keep door closed to generic AIDS drugs.
    Cherry M
    Nature; 2001 Apr; 410(6832):1013. PubMed ID: 11323627
    [No Abstract]   [Full Text] [Related]  

  • 6. AIDS drugs. Brazil, Thailand override big pharma patents.
    Cohen J
    Science; 2007 May; 316(5826):816. PubMed ID: 17495145
    [No Abstract]   [Full Text] [Related]  

  • 7. Canada to change patent law to allow export of cheap drugs.
    Kondro W
    Lancet; 2003 Oct; 362(9392):1290. PubMed ID: 14577437
    [No Abstract]   [Full Text] [Related]  

  • 8. Brazil and USA at loggerheads over production of generic antiretrovirals.
    Ahmad K
    Lancet; 2001 Feb; 357(9254):453. PubMed ID: 11273079
    [No Abstract]   [Full Text] [Related]  

  • 9. Next steps against AIDS.
    Nature; 2001 Apr; 410(6832):1009. PubMed ID: 11323620
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmaceutical companies abandon case against South Africa: victory for people with HIV/AIDS.
    Kleinsmidt A
    Can HIV AIDS Policy Law Rev; 2001; 6(1-2):75-7. PubMed ID: 11837037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug firms take South Africa's government to court.
    Baleta A
    Lancet; 2001 Mar; 357(9258):775. PubMed ID: 11253978
    [No Abstract]   [Full Text] [Related]  

  • 12. Competition watchdog finds new target: overpriced generics.
    Hawkes N
    BMJ; 2016 Dec; 355():i6712. PubMed ID: 27974337
    [No Abstract]   [Full Text] [Related]  

  • 13. The ongoing regulation of generic drugs.
    Frank RG
    N Engl J Med; 2007 Nov; 357(20):1993-6. PubMed ID: 18003956
    [No Abstract]   [Full Text] [Related]  

  • 14. Generic drug firm settles claim that it was paid to stay out of market.
    Dyer O
    BMJ; 2015 Apr; 350():h2282. PubMed ID: 25920419
    [No Abstract]   [Full Text] [Related]  

  • 15. Cut-rate AIDS.
    Golden F
    Time; 2001 Mar; 157(11):68. PubMed ID: 11276822
    [No Abstract]   [Full Text] [Related]  

  • 16. Competition body rules that drug companies "abused" their position.
    Sidley P
    BMJ; 2003 Oct; 327(7421):946. PubMed ID: 14576226
    [No Abstract]   [Full Text] [Related]  

  • 17. GSK and Boehringer agree to generic AIDS drugs deal.
    Nelson K
    Lancet; 2003 Dec; 362(9401):2074. PubMed ID: 14700066
    [No Abstract]   [Full Text] [Related]  

  • 18. Just the medicine. Cheaper AIDS drugs.
    Whitelaw K
    US News World Rep; 2001 Mar; 130(12):31. PubMed ID: 11277041
    [No Abstract]   [Full Text] [Related]  

  • 19. Generic drugs.
    AIDS Policy Law; 1999 Nov; 14(21):16. PubMed ID: 11367114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceuticals and medical devices: cost savings. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2010 Jan; ():1-18. PubMed ID: 20213921
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.